DE60334400D1 - Neue polynukleotid- und polypeptidsequenzen und deren verwendungen - Google Patents

Neue polynukleotid- und polypeptidsequenzen und deren verwendungen

Info

Publication number
DE60334400D1
DE60334400D1 DE60334400T DE60334400T DE60334400D1 DE 60334400 D1 DE60334400 D1 DE 60334400D1 DE 60334400 T DE60334400 T DE 60334400T DE 60334400 T DE60334400 T DE 60334400T DE 60334400 D1 DE60334400 D1 DE 60334400D1
Authority
DE
Germany
Prior art keywords
polypeptide sequences
new polynucleotide
polynucleotide
new
dega
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60334400T
Other languages
English (en)
Inventor
Daniel Pereira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ImClone LLC
Original Assignee
ImClone LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ImClone LLC filed Critical ImClone LLC
Application granted granted Critical
Publication of DE60334400D1 publication Critical patent/DE60334400D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE60334400T 2002-06-28 2003-06-30 Neue polynukleotid- und polypeptidsequenzen und deren verwendungen Expired - Lifetime DE60334400D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39267502P 2002-06-28 2002-06-28
PCT/US2003/020601 WO2004003165A2 (en) 2002-06-28 2003-06-30 Novel polynucleotide and polypeptide sequences and uses thereof

Publications (1)

Publication Number Publication Date
DE60334400D1 true DE60334400D1 (de) 2010-11-11

Family

ID=30000915

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60334400T Expired - Lifetime DE60334400D1 (de) 2002-06-28 2003-06-30 Neue polynukleotid- und polypeptidsequenzen und deren verwendungen

Country Status (9)

Country Link
US (1) US20070128595A1 (de)
EP (2) EP1572952B1 (de)
JP (1) JP4416650B2 (de)
AT (1) ATE483030T1 (de)
AU (1) AU2003261102A1 (de)
CA (1) CA2491083A1 (de)
DE (1) DE60334400D1 (de)
ES (1) ES2350828T3 (de)
WO (1) WO2004003165A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1578797A1 (de) * 2002-12-13 2005-09-28 Licentia Ltd. Das transmembranproteinamigo und dessen verwendungen
US8211630B2 (en) 2006-04-18 2012-07-03 Perseus Proteomics Inc. Diagnostic agent and therapeutic agent for pancreatic cancer
KR20090039748A (ko) * 2006-07-20 2009-04-22 노파르티스 아게 암의 치료, 진단 또는 검출을 위한 ａｍｉｇｏ-2 억제제
JP2010280568A (ja) * 2007-09-21 2010-12-16 Perseus Proteomics Inc 肺癌、前立腺癌、乳癌、卵巣癌、及びメラノーマの診断薬および治療剤
JP2011001267A (ja) * 2007-10-17 2011-01-06 Univ Of Tokyo 大腸癌治療薬

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
WO2001053486A1 (en) * 1999-03-08 2001-07-26 Genentech, Inc. Compositions and methods for the treatment of tumor
WO2001053455A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2001234944A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
JP2003135075A (ja) * 2001-11-05 2003-05-13 Research Association For Biotechnology 新規な全長ｃＤＮＡ
EP1578797A1 (de) * 2002-12-13 2005-09-28 Licentia Ltd. Das transmembranproteinamigo und dessen verwendungen

Also Published As

Publication number Publication date
WO2004003165A3 (en) 2006-07-20
ES2350828T3 (es) 2011-01-27
CA2491083A1 (en) 2004-01-08
JP4416650B2 (ja) 2010-02-17
EP1572952B1 (de) 2010-09-29
ATE483030T1 (de) 2010-10-15
AU2003261102A8 (en) 2004-01-19
AU2003261102A1 (en) 2004-01-19
JP2006508641A (ja) 2006-03-16
EP1572952A4 (de) 2007-08-29
US20070128595A1 (en) 2007-06-07
WO2004003165A2 (en) 2004-01-08
WO2004003165A9 (en) 2004-04-01
EP1572952A2 (de) 2005-09-14
EP2275573A1 (de) 2011-01-19

Similar Documents

Publication Publication Date Title
NZ593289A (en) Anti-neuropilin-1 antibodies for treating angiogenesis
TR200301846T2 (tr) Cripto bloke edici Antikorlar ve bu antikorların kullanımları.
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
DK1615952T3 (da) Fremgangsmåder til behandling af betændelsestilstande med specifikke, til humant angiopoietin-2-bindende midler
EA201100694A1 (ru) Антитело к cd38 человека и его применение
GB0315450D0 (en) Biological products
MX2007008017A (es) Polipeptidos que se ligan a br3 y usos de los mismos.
DE502005009389D1 (de) Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern
DE60223547D1 (de) Gangliosid-assoziierte rekombinante antikörper und deren verwendung bei der diagnose und behandlung von tumoren
ATE544780T1 (de) Hybrid-polypeptide mit eingefügten sequenzmotiven und ihre verwendungen
DK1572087T3 (da) Antistoffer med cancerantigen TMEFF2 og anvendelser deraf
DE602006018424D1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
ZA200500882B (en) Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis of treatment or liver disorders and epithelial cancer
ATE407698T1 (de) Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
ATE483806T1 (de) Polynukleotide, welche für mitglieder der humanen b lymphozyten-aktivierendes antigen familie kodieren, und von diesen kodierte polypeptide
ATE467124T1 (de) Mit prp sp sc/sp wechselwirkende moleküle und deren verwendung
ATE543833T1 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
DE60334400D1 (de) Neue polynukleotid- und polypeptidsequenzen und deren verwendungen
RS20050577A (en) Compositions and methods for treating cancer using igsf9 and liv-1
ATE494307T1 (de) Neoplasma-spezifische antikörper und deren verwendungen
DE60319135D1 (de) Peptide, die die heparinbindungsdomäne von vegf und vegfr-2 binden
ATE419861T1 (de) Peptide mit homing für lymphgefässtumor und ihre verwendung
WO2005094159A3 (en) Methods of identifying neoplasm-specific antibodies and uses thereof
ATE492564T1 (de) Ephb4-bindende antikörper zur inhibierung von angiogenese und tumorwachstum

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN